PCN19 THE COST-EFFECTIVENESS ANALYSIS RECOMBINANT HUMAN ERYTHROPOIETIN GROWTH FACTORS VS. TRANSFUSION IN CHEMOTHERAPY CANCER PATIENTS
May 1, 2004, 00:00
10.1016/S1098-3015(10)62161-4
https://www.valueinhealthjournal.com/article/S1098-3015(10)62161-4/fulltext
Title :
PCN19 THE COST-EFFECTIVENESS ANALYSIS RECOMBINANT HUMAN ERYTHROPOIETIN GROWTH FACTORS VS. TRANSFUSION IN CHEMOTHERAPY CANCER PATIENTS
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(10)62161-4&doi=10.1016/S1098-3015(10)62161-4
First page :
Section Title :
Open access? :
No
Section Order :
100